Table 11B: Change in NVI on follow-up
| Route |
Patients of NVI 1 week prior |
At 4th week presence |
p-value | Significance |
At 4th week presence |
p-value | Significance | ||||||||
| Intracameral | 8 | 0 | 0.004 | S | 1 | 0.008 | S | ||||||||
| Intravitreal | 10 | 1 | 0.003 | S | 1 | 0.003 | S | ||||||||
| Combined | 2 | 00 | 0.002 | S | 0 | 0.002 | S |
S: Significant